Researchers conducted a large trial to see if a mobile application called RJBC-APP could help patients with early-stage breast cancer follow their treatment plans. The study included nearly 500 women who were undergoing adjuvant therapy after their initial diagnosis.
The results showed that while the app did not significantly improve overall completion rates at the 12-month mark, it did show promise in specific areas. Specifically, patients under age 50 and those using the app during the first three months of treatment had higher completion rates compared to those receiving standard care.
Because these specific findings for younger patients are preliminary, they are currently considered hypothesis-generating. This means more research is needed to confirm if the app consistently helps different groups over longer periods. For now, the app shows potential as a supportive tool rather than a proven replacement for standard clinical management.
